Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Chemistry ; 25(53): 12275-12280, 2019 Sep 20.
Article in English | MEDLINE | ID: mdl-31389071

ABSTRACT

A range of oxobis(phenyl-1,3-butanedione) vanadium(IV) complexes have been successfully synthesized from cheap starting materials and a simple and solvent-free one-pot dry-melt reaction. This direct, straightforward, fast and alternative approach to inorganic synthesis has the potential for a wide range of applications. Analytical studies confirm their successful synthesis, purity and solid-state coordination, and we report the use of such complexes as potential drug candidates for the treatment of cancer. After a 24 hour incubation of A549 lung carcinoma cells with the compounds, they reveal cytotoxicity values elevenfold greater than cisplatin and remain non-toxic towards normal cell types. Additionally, the complexes are stable over a range of physiological pH values and show the potential for interactions with bovine serum albumin.


Subject(s)
Antineoplastic Agents/pharmacology , Cisplatin/toxicity , Coordination Complexes/chemical synthesis , Vanadium/chemistry , Animals , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/chemistry , Cattle , Cisplatin/chemistry , Coordination Complexes/chemistry , Coordination Complexes/pharmacology , Humans , Serum Albumin, Bovine/chemistry , Serum Albumin, Bovine/metabolism , Solvents
2.
Biomater Sci ; 6(8): 2101-2109, 2018 Jul 24.
Article in English | MEDLINE | ID: mdl-29881840

ABSTRACT

Microbial keratitis can arise from penetrating injuries to the cornea. Corneal trauma promotes bacterial attachment and biofilm growth, which decrease the effectiveness of antimicrobials against microbial keratitis. Improved therapeutic efficacy can be achieved by reducing microbial burden prior to antimicrobial therapy. This paper assesses a highly-branched poly(N-isopropyl acrylamide) with vancomycin end groups (HB-PNIPAM-van), for reducing bacterial attachment and biofilm formation. The polymer lacked antimicrobial activity against Staphylococcus aureus, but significantly inhibited biofilm formation (p = 0.0008) on plastic. Furthermore, pre-incubation of S. aureus cells with HB-PNIPAM-van reduced cell attachment by 50% and application of HB-PNIPAM-van to infected ex vivo rabbit corneas caused a 1-log reduction in bacterial recovery, compared to controls (p = 0.002). In conclusion, HB-PNIPAM-van may be a useful adjunct to antimicrobial therapy in the treatment of corneal infections.


Subject(s)
Acrylic Resins/pharmacology , Anti-Bacterial Agents/pharmacology , Biofilms/drug effects , Cornea/drug effects , Staphylococcal Infections/drug therapy , Staphylococcus aureus/drug effects , Vancomycin/pharmacology , Acrylic Resins/chemistry , Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/chemistry , Cell Survival/drug effects , Cornea/metabolism , Lasers , Microbial Sensitivity Tests , Particle Size , Reactive Oxygen Species/analysis , Reactive Oxygen Species/metabolism , Staphylococcal Infections/metabolism , Staphylococcus aureus/cytology , Staphylococcus aureus/metabolism , Surface Properties , Vancomycin/chemistry
3.
Sci Rep ; 6: 22962, 2016 Mar 14.
Article in English | MEDLINE | ID: mdl-26973255

ABSTRACT

Keratin 9 was recently identified as an important component of a biomarker panel which demonstrated a high diagnostic accuracy (87%) for Alzheimer's disease (AD). Understanding how a protein which is predominantly expressed in palmoplantar epidermis is implicated in AD may shed new light on the mechanisms underlying the disease. Here we use immunoassays to examine blood plasma expression patterns of Keratin 9 and its relationship to other AD-associated proteins. We correlate this with the use of an in silico analysis tool VisANT to elucidate possible pathways through which the involvement of Keratin 9 may take place. We identify possible links with Dickkopf-1, a negative regulator of the wnt pathway, and propose that the abnormal expression of Keratin 9 in AD blood and cerebrospinal fluid may be a result of blood brain barrier dysregulation and disruption of the ubiquitin proteasome system. Our findings suggest that dysregulated Keratin 9 expression is a consequence of AD pathology but, as it interacts with a broad range of proteins, it may have other, as yet uncharacterized, downstream effects which could contribute to AD onset and progression.


Subject(s)
Alzheimer Disease/metabolism , Biomarkers/analysis , Keratin-9/analysis , Signal Transduction , Aged , Aged, 80 and over , Alzheimer Disease/diagnosis , Alzheimer Disease/physiopathology , Amyloid beta-Peptides/metabolism , Apolipoproteins E/metabolism , Biomarkers/blood , Blood-Brain Barrier/metabolism , Cohort Studies , Computational Biology/methods , Female , Humans , Immunoassay/methods , Intercellular Signaling Peptides and Proteins/metabolism , Keratin-9/metabolism , Keratin-9/physiology , Male , Peptide Fragments/metabolism , Proteasome Endopeptidase Complex/metabolism , Protein Binding , Protein Interaction Maps , tau Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...